Early Gene Expression in Salivary Gland After Isoproterenol Treatment

ABSTRACT Isoproterenol, a β‐adrenergic agonist, has been shown to induce salivary gland hyperplasia. However, the mechanism involved in this pharmacological phenomenon is not well understood. To gain a better understanding of the underlying changes, including genes, networks and pathways altered by...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of cellular biochemistry 2015-03, Vol.116 (3), p.431-437
Hauptverfasser: Zhou, Yi, Chen, Hung-I H., Lin, AL, Dang, H, Haack, Karin, Cole, Shelley A., Huang, Yufei, Yu, Haiyang, Chen, Yidong, Yeh, Chih-Ko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:ABSTRACT Isoproterenol, a β‐adrenergic agonist, has been shown to induce salivary gland hyperplasia. However, the mechanism involved in this pharmacological phenomenon is not well understood. To gain a better understanding of the underlying changes, including genes, networks and pathways altered by isoproterenol, microarray‐based gene expression analysis was conducted on rat parotid glands at 10, 30, and 60 min after isoproterenol injection. After isoproterenol treatment, the number of differentially expressed genes was increased in a time‐dependent manner. Pathway analysis showed that cell hyperplasia, p38MAPK, and IGF‐1 were the most altered function, network and pathway, respectively. The balanced regulation of up‐ and down‐expression of genes related to cell proliferation/survival may provide a better understanding of the mechanism of isoproterenol‐induced parotid gland enlargement without tumor transformation. J. Cell. Biochem. 116: 431–437, 2015. © 2014 Wiley Periodicals, Inc.
ISSN:0730-2312
1097-4644
DOI:10.1002/jcb.24995